Aflac Incorporated (NYSE:AFL) Stock Holdings Cut by Congress Wealth Management LLC DE

Congress Wealth Management LLC DE lessened its position in Aflac Incorporated (NYSE:AFL) by 52.3% during the fourth quarter, according to its most recent 13F filing with the SEC. The institutional investor owned 80,155 shares of the financial services provider’s stock after selling 87,817 shares during the period. Congress Wealth Management LLC DE’s holdings in Aflac were worth $8,291,000 at the end of the most recent reporting period.

Other institutional investors have also modified their holdings of the company. Whipplewood Advisors LLC bought a new stake in Aflac during the fourth quarter worth approximately $26,000. BankPlus Trust Department bought a new stake in shares of Aflac during the 4th quarter worth $34,000. Curio Wealth LLC acquired a new position in shares of Aflac in the 4th quarter worth $36,000. Raelipskie Partnership acquired a new stake in shares of Aflac during the third quarter worth $38,000. Finally, OFI Invest Asset Management purchased a new stake in shares of Aflac during the fourth quarter valued at $38,000. Institutional investors and hedge funds own 67.44% of the company’s stock.

Insider Activity at Aflac

In other news, Director Charles D. Lake II sold 29,802 shares of Aflac stock in a transaction that occurred on Monday, March 10th. The stock was sold at an average price of $107.29, for a total transaction of $3,197,456.58. Following the sale, the director now owns 49,962 shares of the company’s stock, valued at approximately $5,360,422.98. This trade represents a 37.36 % decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, Director Joseph L. Moskowitz sold 1,000 shares of the company’s stock in a transaction on Friday, March 7th. The shares were sold at an average price of $107.63, for a total value of $107,630.00. Following the completion of the transaction, the director now owns 25,393 shares of the company’s stock, valued at $2,733,048.59. The trade was a 3.79 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last 90 days, insiders sold 55,546 shares of company stock worth $5,863,616. Company insiders own 0.90% of the company’s stock.

Aflac Stock Performance

AFL opened at $109.56 on Wednesday. The company has a quick ratio of 0.08, a current ratio of 0.10 and a debt-to-equity ratio of 0.29. The stock’s 50 day moving average price is $106.21 and its two-hundred day moving average price is $107.62. The firm has a market capitalization of $59.88 billion, a P/E ratio of 11.41, a price-to-earnings-growth ratio of 3.24 and a beta of 0.93. Aflac Incorporated has a 12-month low of $79.31 and a 12-month high of $115.50.

Aflac (NYSE:AFL) last announced its earnings results on Wednesday, February 5th. The financial services provider reported $1.56 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $1.63 by ($0.07). Aflac had a return on equity of 16.20% and a net margin of 28.76%. On average, equities analysts forecast that Aflac Incorporated will post 6.88 earnings per share for the current year.

Wall Street Analysts Forecast Growth

Several analysts have issued reports on the company. Wells Fargo & Company cut their price objective on Aflac from $104.00 to $102.00 and set an “equal weight” rating on the stock in a report on Wednesday, February 19th. Barclays reduced their price target on shares of Aflac from $98.00 to $95.00 and set an “underweight” rating for the company in a research report on Friday, February 7th. Piper Sandler lowered their price objective on shares of Aflac from $122.00 to $118.00 and set an “overweight” rating on the stock in a research report on Friday, February 7th. Evercore ISI reduced their target price on Aflac from $104.00 to $102.00 and set an “underperform” rating for the company in a report on Wednesday, December 4th. Finally, StockNews.com upgraded Aflac from a “sell” rating to a “hold” rating in a report on Friday, February 14th. Two equities research analysts have rated the stock with a sell rating, eleven have issued a hold rating and two have issued a buy rating to the company’s stock. According to data from MarketBeat, Aflac has an average rating of “Hold” and an average target price of $103.36.

Aflac Company Profile

Aflac Incorporated, through its subsidiaries, provides supplemental health and life insurance products. The company operates through Aflac Japan and Aflac U.S. segments. The Aflac Japan segment offers cancer, medical, nursing care, work leave, GIFT, and whole and term life insurance products, as well as WAYS and child endowment plans under saving type insurance products in Japan.